Paraflex and Effient drug interactions - a phase IV clinical study of FDA data
Summary:
We study 9,724 people who take Paraflex (chlorzoxazone) and Effient (prasugrel hydrochloride). There is no drug interaction reported.
The study analyzes what interactions people have when they take Paraflex and Effient. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Paraflex?
Paraflex has active ingredients of chlorzoxazone. eHealthMe is studying from 242 Paraflex users. Check the latest studies of Paraflex.
What is Effient?
Effient has active ingredients of prasugrel hydrochloride. It is often used in stent. eHealthMe is studying from 9,482 Effient users. Check the latest studies of Effient.
No report is found.
Do you take Paraflex and Effient?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on chlorzoxazone and prasugrel hydrochloride (the active ingredients of Paraflex and Effient, respectively), and Paraflex and Effient (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Imbruvica cause Irritable Bowel Syndrome? - 5 seconds ago
- Could Olanzapine cause Neutrophil Count Increased? - 21 seconds ago
- Could Piroxicam cause Musculoskeletal Discomfort? - 21 seconds ago
- Could Singulair cause Muscle Mass? - 27 seconds ago
- Drug interactions of Hydrochlorothiazide and Cannabis Sativa - 28 seconds ago
- Acetylcysteine vs. Sudafed 12 Hour, side effect and effectiveness comparison - 52 seconds ago
- Could Klonopin cause Uterine Disorder? - a minute ago
- Could Sitagliptin Phosphate cause Acute Myocardial Infarction? - a minute ago
- Drug interactions of Premarin and Dyrenium - a minute ago
- Could Xgeva cause Metabolic Acidosis? - a minute ago